5-160565521-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_025153.3(ATP10B):āc.4318C>Gā(p.Gln1440Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000167 in 1,614,140 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_025153.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP10B | NM_025153.3 | c.4318C>G | p.Gln1440Glu | missense_variant | 26/26 | ENST00000327245.10 | NP_079429.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP10B | ENST00000327245.10 | c.4318C>G | p.Gln1440Glu | missense_variant | 26/26 | 1 | NM_025153.3 | ENSP00000313600 | P1 | |
ATP10B | ENST00000642502.1 | c.4234C>G | p.Gln1412Glu | missense_variant | 21/21 | ENSP00000493802 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 249050Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135088
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461818Hom.: 0 Cov.: 29 AF XY: 0.00000550 AC XY: 4AN XY: 727218
GnomAD4 genome AF: 0.000118 AC: 18AN: 152322Hom.: 1 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2022 | The c.4318C>G (p.Q1440E) alteration is located in exon 26 (coding exon 22) of the ATP10B gene. This alteration results from a C to G substitution at nucleotide position 4318, causing the glutamine (Q) at amino acid position 1440 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at